STOCK TITAN

Hims & Hers Health, Inc. - HIMS STOCK NEWS

Welcome to our dedicated page for Hims & Hers Health news (Ticker: HIMS), a resource for investors and traders seeking the latest updates and insights on Hims & Hers Health stock.

Hims & Hers Health, Inc. (HIMS) is a cutting-edge telehealth company, headquartered in San Francisco, California, that revolutionizes the way people access healthcare. Founded in 2013, the company provides a multi-specialty platform connecting consumers to licensed healthcare professionals, offering a seamless path to high-quality medical care for various conditions.

Hims & Hers Health, Inc. specializes in a broad range of wellness products and services. Their portfolio includes treatments for hair loss, sexual wellness products, skincare lines, and oral care solutions. The company also diversifies its offerings through an exclusive range of men's fashion items including sweaters, jackets, corduroy, sport coats, wool overcoats, leather boots, flannel shirts, caps, and candles. All products are conveniently available for purchase through their online platform.

The telehealth services provided by Hims & Hers are comprehensive, covering mental health, sexual health, dermatology, primary care, and more. This robust platform ensures consumers receive professional medical consultations from the comfort of their homes.

Hims & Hers Health, Inc. continues to innovate and expand its services to meet the evolving needs of its customers. Recent achievements include advancements in their telehealth technology, expanding partnerships with renowned medical professionals, and enhancing their product lines. The company is financially sound and continues to grow, reflecting positive market performance and consumer trust.

For the latest updates, financial reports, and company news, Hims & Hers Health remains a significant player in both the wellness product market and the telehealth industry.

Rhea-AI Summary
Hims & Hers Health to report Q3 2023 financial results
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.48%
Tags
-
Rhea-AI Summary
Hims & Hers reports Q2 2023 revenue of $207.9 million, up 83% YoY. Net loss of $7.2 million; Adjusted EBITDA profitability of $10.6 million. Subscribers grew to 1.3 million, up 74% YoY. Raises full year 2023 revenue guidance to $830M-$850M and Adjusted EBITDA guidance to $35M-$40M.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.82%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.82%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.97%
Tags
-
Rhea-AI Summary
Spruce Point Capital Management, a New York-based investment management firm, has issued a report outlining concerns about Hims & Hers Health. The report highlights potential violations of corporate practice of medicine regulations, issues with the quality of healthcare provided, and operational risks related to third-party pharmacy partners. Spruce Point believes that Hims & Hers faces long-term downside risk to its share price.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.07%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.56%
Tags
none
Rhea-AI Summary
Laudio, the healthcare management solution, has raised $13 million in a Series B funding round led by Define Ventures. The funding brings Laudio's total funding to $25 million and highlights the growing demand for solutions that increase labor productivity and address burnout in frontline workers. The company plans to invest in platform development, scaling growth, and expanding its sales and marketing efforts.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.11%
Tags
AI
-
News
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.68%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-10.13%
Tags
Rhea-AI Summary

Hims & Hers Health, Inc. (NYSE: HIMS) is set to report its first quarter 2023 financial results on May 8, 2023, after market close. A live conference call will follow at 5:00 p.m. ET, accessible by U.S. and international participants. In addition, company executives will participate in the Bank of America Merrill Lynch Global Healthcare Conference on May 10, 2023, in Las Vegas. Both events will be available via live audio webcast on the Hims & Hers investor relations website, which will archive these sessions for one year. The platform aims to revolutionize health and wellness by providing personalized care and addressing wellness challenges.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
10.33%
Tags

FAQ

What is the current stock price of Hims & Hers Health (HIMS)?

The current stock price of Hims & Hers Health (HIMS) is $26.2 as of December 20, 2024.

What is the market cap of Hims & Hers Health (HIMS)?

The market cap of Hims & Hers Health (HIMS) is approximately 5.8B.

What does Hims & Hers Health, Inc. do?

Hims & Hers Health, Inc. is a telehealth company offering wellness products and connecting consumers to licensed healthcare professionals for various medical conditions.

Where is Hims & Hers Health, Inc. based?

The company is based in San Francisco, California.

When was Hims & Hers Health, Inc. founded?

The company was founded in 2013.

What types of products does Hims & Hers offer?

Hims & Hers offers hair loss prevention medicines, sexual wellness products, skincare products, oral care solutions, as well as men's fashion items like sweaters, jackets, and leather boots.

What medical services are available through Hims & Hers?

The company provides telehealth services covering mental health, sexual health, dermatology, primary care, and more.

How can I purchase products from Hims & Hers?

Products are available for purchase online through their platform.

How is Hims & Hers Health, Inc. performing financially?

Hims & Hers Health, Inc. is financially sound and continues to grow, reflecting positive market performance.

What recent achievements has Hims & Hers Health, Inc. made?

Recent achievements include advancements in telehealth technology, expanding partnerships with medical professionals, and enhancing product lines.

Does Hims & Hers collaborate with healthcare professionals?

Yes, Hims & Hers connects consumers with licensed healthcare professionals for consultations and medical care.

What makes Hims & Hers Health, Inc. unique?

Hims & Hers combines a broad range of wellness products with comprehensive telehealth services, enabling convenient access to high-quality medical care from home.

Hims & Hers Health, Inc.

NYSE:HIMS

HIMS Rankings

HIMS Stock Data

5.76B
184.42M
11.37%
65.88%
18.09%
Household & Personal Products
Services-offices & Clinics of Doctors of Medicine
Link
United States of America
SAN FRANCISCO